Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram in Adolescents with MDD or Anxiety
NCT03122158Phase 4Unknown
- Sponsor
- Erzurum City Hospital
- Start
- Apr 2017
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram in major depressive disorder (MDD), anxiety disorders, sponsored by Erzurum City Hospital. Status: unknown.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)anxiety disorders
Beyond the preview
Go deeper on NCT03122158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03122158.